Preserved cardiac mitochondrial function and reduced ischaemia/reperfusion injury afforded by chronic continuous hypoxia: role of opioid receptors

Clinical and Experimental Pharmacology & Physiology
L N MaslovYury B Lishmanov

Abstract

Chronic continuous normobaric hypoxia (CNH) increases cardiac tolerance to acute ischaemia/reperfusion injury. The objective of this study was to find out whether the cardioprotective effect of CNH mediated by opioid receptors is associated with preservation of mitochondrial function. Rats were adapted to CNH (12% oxygen) for 3 weeks. Isolated perfused hearts were subjected to 45 min of global ischaemia and 30 min of reperfusion; subgroups were pretreated with non-selective opioid receptor antagonist naloxone (300 nmol/L) for 10 min. Cardiac contractile function, creatine kinase activity in coronary effluent, mitochondrial respiration rate, and calcium retention capacity were assessed. Adaptation to CNH decreased myocardial creatine kinase release during reperfusion and improved the post-ischaemic recovery of contractile function, mitochondrial state 3 and uncoupled respiration rates, and calcium retention capacity compared to the normoxic group. These protective effects were completely abolished by naloxone. The contractile recovery positively correlated with state 3 respiration and calcium retention capacity. The results suggest that the preserved mitochondrial function contributes to the protected cardiac phenotype afforded ...Continue Reading

References

Jul 1, 1988·The American Journal of Physiology·L E CostaA C Taquini
Sep 2, 1999·Journal of Cardiovascular Pharmacology·E GeshiT Katagiri
Jan 24, 2003·Journal of Bioenergetics and Biomembranes·Xiulian ChenDenis M Medeiros
Apr 8, 2003·Journal of Bioenergetics and Biomembranes·Baltazar D Reynafarje, Emilio Marticorena
Jun 24, 2003·Journal of Molecular and Cellular Cardiology·Garrett J Gross
Aug 21, 2004·American Journal of Physiology. Heart and Circulatory Physiology·Colleen M FitzpatrickJohn E Baker
Feb 9, 2005·Journal of Molecular and Cellular Cardiology·Laurent ArgaudMichel Ovize
Jun 1, 2005·Vascular Pharmacology·Jason N PeartGarrett J Gross
Nov 18, 2005·Journal of Molecular and Cellular Cardiology·Wei-Zhong ZhuZhao-Nian Zhou
Feb 25, 2006·Cardiovascular Research·Fabio Di Lisa, Paolo Bernardi
Mar 16, 2006·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Indrapal N SinghEdward D Hall
Dec 13, 2006·Bulletin of Experimental Biology and Medicine·L N MaslovP R Oeltgen
Apr 20, 2007·Respiratory Physiology & Neurobiology·B Ostadal, F Kolar
May 23, 2007·Heart Failure Reviews·Fabio Di LisaPaolo Bernardi
May 23, 2007·Heart Failure Reviews·James M DowneyMichael V Cohen
Jul 17, 2007·Biochimica Et Biophysica Acta·Andrew P HalestrapIgor Khaliulin
Nov 5, 2008·Circulation·Gerd HeuschRainer Schulz
Jun 16, 2009·American Journal of Physiology. Heart and Circulatory Physiology·Zhuo YuHuang-Tian Yang
Jan 13, 2010·Basic Research in Cardiology·Gerd HeuschRainer Schulz
Feb 8, 2011·Biochimica Et Biophysica Acta·Fabio Di LisaPaolo Bernardi
Feb 22, 2014·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Tsung-I ChenKun-Ta Yang

❮ Previous
Next ❯

Citations

Dec 26, 2016·Peptides·Richard J Bodnar
Apr 28, 2020·Bulletin of Experimental Biology and Medicine·N V NaryzhnayaL N Maslov
Jun 1, 2020·Bulletin of Experimental Biology and Medicine·E S ProkudinaL N Maslov
Jun 4, 2017·Bulletin of Experimental Biology and Medicine·Yu B LishmanovL N Maslov

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.